Targeting mTOR Shows Promise in Cutaneous Sarcoidosis
Vienna researchers reported that 7 of 10 patients treated with systemic sirolimus had noted improvements in skin lesions, which continued for up to 2 years of follow-up.
Source: medscape.com
Sarcoidosis Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sarcoidosis Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sarcoidosis Program Today - Breaking & Trending Today